Timisnar - Biomarkers Substudy (Timisnar-mirna)

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

April 1, 2025

Study Completion Date

April 1, 2025

Conditions
Rectal Cancer
Interventions
DIAGNOSTIC_TEST

miRNA

"15 ml of whole blood samples are collected in Vacutainer tubes with spray-coated K2EDTA and stored at room temperature. To minimize the hemolysis and nucleic acids degradation, plasma separation undergoes within 2 h.~Within 1 h, tubes are subjected to a first centrifugation step at 2200 x g and room temperature for 15 min. Plasma supernatants are transferred to 15 mL tubes, carefully avoiding contact with the lymphocytic ring, and tubes are centrifuged a second time at 3000 x g and RT for 10 min to remove cellular debris.~Plasma samples are then collected into 1.5 mL cryovials and all the aliquots are stored at -80 °C."

Trial Locations (1)

Unknown

RECRUITING

SS. Antonio e Biagio e Cesare Arrigo, Alessandria

All Listed Sponsors
lead

Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria

OTHER

NCT03962088 - Timisnar - Biomarkers Substudy (Timisnar-mirna) | Biotech Hunter | Biotech Hunter